Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
After-Hours: 20:00
Relay Therapeutics Price to Book Value: 0.9478 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 0.9478 |
November 21, 2024 | 0.9258 |
November 20, 2024 | 0.9298 |
November 19, 2024 | 0.9578 |
November 18, 2024 | 0.9757 |
November 15, 2024 | 1.019 |
November 14, 2024 | 1.117 |
November 13, 2024 | 1.159 |
November 12, 2024 | 1.185 |
November 11, 2024 | 1.229 |
November 08, 2024 | 1.237 |
November 07, 2024 | 1.225 |
November 06, 2024 | 1.247 |
November 05, 2024 | 1.187 |
November 04, 2024 | 1.167 |
November 01, 2024 | 1.165 |
October 31, 2024 | 1.121 |
October 30, 2024 | 1.136 |
October 29, 2024 | 1.174 |
October 28, 2024 | 1.200 |
October 25, 2024 | 1.198 |
October 24, 2024 | 1.232 |
October 23, 2024 | 1.253 |
October 22, 2024 | 1.325 |
October 21, 2024 | 1.279 |
Date | Value |
---|---|
October 18, 2024 | 1.339 |
October 17, 2024 | 1.321 |
October 16, 2024 | 1.353 |
October 15, 2024 | 1.341 |
October 14, 2024 | 1.343 |
October 11, 2024 | 1.353 |
October 10, 2024 | 1.309 |
October 09, 2024 | 1.275 |
October 08, 2024 | 1.243 |
October 07, 2024 | 1.261 |
October 04, 2024 | 1.299 |
October 03, 2024 | 1.291 |
October 02, 2024 | 1.291 |
October 01, 2024 | 1.303 |
September 30, 2024 | 1.408 |
September 27, 2024 | 1.825 |
September 26, 2024 | 1.81 |
September 25, 2024 | 1.727 |
September 24, 2024 | 1.783 |
September 23, 2024 | 1.817 |
September 20, 2024 | 1.834 |
September 19, 2024 | 1.922 |
September 18, 2024 | 1.854 |
September 17, 2024 | 1.859 |
September 16, 2024 | 1.984 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9258
Minimum
Nov 21 2024
7.248
Maximum
Jan 22 2021
2.961
Average
2.409
Median
Jun 27 2022
Price to Book Value Benchmarks
Pfizer Inc | 1.575 |
Summit Therapeutics Inc | 32.00 |
Biomarin Pharmaceutical Inc | 2.262 |
Lexicon Pharmaceuticals Inc | 1.748 |
Arbutus Biopharma Corp | 6.222 |
Price to Book Value Related Metrics
PS Ratio | 17.77 |
Price | 4.75 |
Earnings Yield | -54.95% |
Market Cap | 795.07M |